What oral alternatives would you recommend as opposed to injectable GnRH agonists for those who do not wish to come to clinic due to COVID-19?

Topics: Radiation Oncology • Genitourinary Cancers • COVID-19

This applies to both de novo cases and patients who have previously received injectable agents.

Answer from: Radiation Oncologist at Community Practice

Casodex is an option. Due to liver toxicity, they would need LFTs checked before and at a future interval, effectively requiring them 3 visits to a health care facility—labs, pharmacy, labs. A single 6 month injection seems like a better proposition.

Comments

Radiation Oncologist at Abramson Cancer Center, University of Pennsylvania
I agree with @Manuj Agarwal. In addition, degarel...

Radiation Oncologist at Huntsman Cancer Institute - University of Utah Health Care
Agreed. It's worth adding that the need for breast...

Related Questions